Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation-Reference-Cited by-同舟云学术

Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation

Published:2015-06-26 Issue:9 Volume:50 Page:869-877
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Laguna Theresa A.¹,Reilly Cavan S.²,Williams Cynthia B.¹,Welchlin Cole¹,Wendt Chris H.³

Affiliation:

1. Department of Pediatrics; University of Minnesota Medical School and The University of Minnesota Masonic Children's Hospital; Minneapolis Minnesota

2. School of Public Health; Division of Biostatistics; University of Minnesota; Minneapolis Minnesota

3. Department of Medicine; Division of Pulmonary and Critical Care Medicine; University of Minnesota School of Medicine and Veterans Administration Medical Center; Minneapolis Minnesota

Funder

Cystic Fibrosis Foundation

National Institutes of Health

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.23225/fullpdf

Reference43 articles.

1. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT;Mott;Thorax,2012

2. Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening;Stick;J Pediatr,2009